Table 2 Description of the study population
From: Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation
Characteristic | Study Population n (%) |
|---|---|
Age (years), mean ± std dev | 62.2 ± 13.0 |
Gender | Â |
   Male | 56 (63.6%) |
   Female | 32 (36.4%) |
Smoking status | Â |
   Never smoker | 11 (12.5%) |
   Ever smoker | 77 (87.5%) |
Alcohol Use | Â |
   Never drinker | 16 (18.2%) |
   Ever drinker | 72 (81.8%) |
Family history | Â |
   Negative | 41 (46.6%) |
   Positive | 47 (53.4%) |
Histology | Â |
   Squamous | 85 (96.6%) |
   Adenoid Cystic | 1 (1.1%) |
   Mucoepidermoid | 2 (2.3%) |
Anatomic site | Â |
   Oral cavity | 50 (56.8%) |
   Oropharynx | 38 (43.2%) |
Stage at diagnosis | Â |
   I | 20 (22.7%) |
   II | 16 (18.2%) |
   III | 17 (19.3%) |
   IV | 35 (39.8%) |
Treatment | Â |
   Surgery only | 44 (50.0%) |
   Surgery and radiotherapy | 39 (44.3%) |
   Surgery and chemoradiation | 5 (5.7%) |